Das Mammakarzinom beim Mann: Eine Herausforderung für den Urologen

Translated title of the contribution: Male breast cancer: A challenge for urologists

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Male breast cancer (male BC) accounts for <1% of all cancers in men, showing an increasing incidence with a peak in the sixth decade. Overall, men experience a worse prognosis than women, probably due to an advanced stage together with the higher age at diagnosis of male patients. Major risk factors for developing male BC include clinical disorders involving hormonal imbalances (excess of estrogen or a deficiency of testosterone as seen in patients with Klinefelter syndrome) and a positive family history for breast cancer. About 90% of male BC are invasive ductal carcinomas. Standard treatment for localized cancer is surgical removal. Adjuvant radiation and systemic therapy are the same as in women with breast cancer. Male BC expresses hormone receptors in about 90% of cases; therefore, tamoxifen is a therapeutic option. A future challenge for the urologist or andrologist is to diagnose the disease at an early stage to improve prognosis.

Translated title of the contributionMale breast cancer: A challenge for urologists
Original languageGerman
Pages (from-to)1142-1148
Number of pages7
JournalUrologe - Ausgabe A
Issue number9
StatePublished - Sep 2010
Externally publishedYes


Dive into the research topics of 'Male breast cancer: A challenge for urologists'. Together they form a unique fingerprint.

Cite this